The Net Margin of Jounce Therapeutics Inc (JNCE) is -62.10%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2022-12-31 | -62.10% |
| 2021-12-31 | -337.73% |
| 2020-12-31 | -70.30% |
| 2019-12-31 | 38.40% |
| 2018-12-31 | -42.02% |
| 2017-12-31 | -22.91% |
| 2016-12-31 | -36.83% |